UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New Kids on the Block: Immature Myeloid Cells in Intestinal Regeneration

Cellular and molecular gastroenterology and hepatology, 2024, Vol.17 (3), p.499-500

2024

Volltextzugriff (PDF)

Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet

Hepatology (Baltimore, Md.), 2021-07, Vol.74 (1), p.164-182

2021

Volltextzugriff (PDF)

Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling

Laboratory investigation, 2020-06, Vol.100 (6), p.837-848

2020

Volltextzugriff (PDF)

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases

Frontiers in medicine, 2020-01, Vol.7, p.15-15

2020

Volltextzugriff (PDF)

Biliary Epithelial Senescence in Liver Disease: There Will Be SASP

Frontiers in molecular biosciences, 2021-12, Vol.8, p.803098-803098

2021

Volltextzugriff (PDF)

Doublecortin‐Like Kinase Protein 1 in Cholangiocarcinoma: Is This the Biomarker and Target We Have Been Looking For?

Hepatology (Baltimore, Md.), 2021-01, Vol.73 (1), p.4-6

2021

Volltextzugriff (PDF)

ASBT Vivo‐Morpholino Decreases Hepatic Mast Cell, Fibrosis and Biliary Senescence in Mdr2‐/‐ Mice

The FASEB journal, 2021-05, Vol.35 (S1), p.n/a, Article fasebj.2021.35.S1.03480

2021

Volltextzugriff (PDF)

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease

Cells (Basel, Switzerland), 2021-08, Vol.10 (8), p.2072

2021

Volltextzugriff (PDF)

Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling

Hepatology communications, 2022-10, Vol.6 (10), p.2715-2731

2022

Volltextzugriff (PDF)

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?

Cells (Basel, Switzerland), 2021-07, Vol.10 (7), p.1692

2021

Volltextzugriff (PDF)

The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling

Cells (Basel, Switzerland), 2022-05, Vol.11 (9), p.1591

2022

Volltextzugriff (PDF)

Alcoholic liver disease and mast cells: What's your gut got to do with it?

Liver research, 2019-03, Vol.3 (1), p.46-54

2019

Volltextzugriff (PDF)

Mast Cell Signaling Regulates Biliary Farnesoid X Receptor and Apical Sodium Bile Acid Transporter Expression During Cholestatic Liver Injury

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

The publish or perish game: an interview with the inventor

FEBS letters, 2024-10

2024

Volltextzugriff (PDF)

Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling

Hepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2684-2698

2021

Volltextzugriff (PDF)

FXR Friend-ChIPs in the Enterohepatic System

Seminars in liver disease, 2023-08, Vol.43 (3), p.267-278

2023

Volltextzugriff (PDF)

Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell–Derived Transforming Growth Factor Beta 1 Signaling

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2397-2410

2021

Volltextzugriff (PDF)

FXR and NASH: an avenue for tissue-specific regulation

Hepatology communications, 2023-05, Vol.7 (5)

2023

Volltextzugriff (PDF)

Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2–/– mice and human cholangiocarcinoma tumorigenesis

Hepatology (Baltimore, Md.), 2018-09, Vol.68 (3), p.1042-1056

2018

Volltextzugriff (PDF)

Mast cells in liver disease progression: An update on current studies and implications

Hepatology (Baltimore, Md.), 2022-01, Vol.75 (1), p.213-218

2022

Volltextzugriff (PDF)

Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes

Journal of hepatology, 2023-01, Vol.78 (1), p.99-113

2023

Volltextzugriff (PDF)

MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giants

AME medical journal, 2018-10, Vol.3, p.98-98

2018

Volltextzugriff (PDF)

Mast Cells Contribute to Hepatic Neurokinin1 Receptor Signaling, Subsequent Biliary Damage and Peribiliary Fibrosis Via TGF‐β1 Signaling in MDR2‐/‐ Mouse Model of Primary Scelrosing Cholangitis

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Mast Cell (MC)‐Induced Cholestasis is Dependent on Apical Sodium Bile Acid Transporter (ASBT) Expression

The FASEB journal, 2022-05, Vol.36 (S1)

2022

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

New Kids on the Block: Immature Myeloid Cells in Intestinal Regeneration

Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet

Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases

Biliary Epithelial Senescence in Liver Disease: There Will Be SASP

Doublecortin‐Like Kinase Protein 1 in Cholangiocarcinoma: Is This the Biomarker and Target We Have Been Looking For?

ASBT Vivo‐Morpholino Decreases Hepatic Mast Cell, Fibrosis and Biliary Senescence in Mdr2‐/‐ Mice

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease

Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?

The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling

Alcoholic liver disease and mast cells: What's your gut got to do with it?

Mast Cell Signaling Regulates Biliary Farnesoid X Receptor and Apical Sodium Bile Acid Transporter Expression During Cholestatic Liver Injury

The publish or perish game: an interview with the inventor

Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling

FXR Friend-ChIPs in the Enterohepatic System

Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell–Derived Transforming Growth Factor Beta 1 Signaling

FXR and NASH: an avenue for tissue-specific regulation

Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2–/– mice and human cholangiocarcinoma tumorigenesis

Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC

Mast cells in liver disease progression: An update on current studies and implications

Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes

MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giants

Mast Cells Contribute to Hepatic Neurokinin1 Receptor Signaling, Subsequent Biliary Damage and Peribiliary Fibrosis Via TGF‐β1 Signaling in MDR2‐/‐ Mouse Model of Primary Scelrosing Cholangitis

Mast Cell (MC)‐Induced Cholestasis is Dependent on Apical Sodium Bile Acid Transporter (ASBT) Expression

Suchergebnisse filtern